| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
|
13,404 |
10,907 |
$2.84M |
| 96361 |
|
5,526 |
3,483 |
$2.49M |
| 99284 |
|
7,359 |
5,668 |
$1.57M |
| 99282 |
|
8,811 |
7,418 |
$963K |
| 99285 |
|
3,764 |
2,986 |
$681K |
| 96365 |
|
2,946 |
1,742 |
$663K |
| 70450 |
|
2,879 |
1,700 |
$577K |
| 99212 |
|
4,348 |
3,681 |
$533K |
| 74177 |
|
1,694 |
1,128 |
$486K |
| 99213 |
|
2,610 |
2,105 |
$294K |
| 96360 |
|
986 |
782 |
$271K |
| 87637 |
|
2,482 |
1,926 |
$210K |
| 99211 |
|
2,017 |
1,703 |
$206K |
| 94640 |
|
1,146 |
818 |
$202K |
| G0378 |
Hospital observation service, per hour |
2,566 |
1,097 |
$107K |
| 96366 |
|
342 |
186 |
$97K |
| 97597 |
|
611 |
214 |
$73K |
| 80053 |
|
8,550 |
6,363 |
$63K |
| 87633 |
|
181 |
165 |
$57K |
| 85025 |
|
9,471 |
6,797 |
$41K |
| 0241U |
|
888 |
633 |
$40K |
| 87651 |
|
969 |
879 |
$33K |
| 87631 |
|
302 |
277 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
333 |
275 |
$29K |
| 84145 |
|
2,603 |
1,930 |
$28K |
| 90834 |
|
561 |
321 |
$24K |
| 80320 |
|
1,132 |
855 |
$22K |
| 99202 |
|
108 |
102 |
$21K |
| 84484 |
|
3,409 |
2,177 |
$19K |
| 99214 |
|
608 |
420 |
$18K |
| 71046 |
|
1,977 |
1,347 |
$17K |
| 81001 |
|
6,522 |
5,199 |
$17K |
| 80306 |
|
1,414 |
1,095 |
$17K |
| 11042 |
|
43 |
26 |
$14K |
| 87635 |
|
285 |
239 |
$13K |
| 93010 |
|
2,927 |
2,178 |
$13K |
| 96372 |
|
3,667 |
2,551 |
$12K |
| 83605 |
|
2,742 |
1,902 |
$12K |
| 80048 |
|
2,661 |
1,780 |
$12K |
| 74176 |
|
42 |
26 |
$11K |
| 87040 |
|
2,766 |
1,268 |
$11K |
| 97110 |
|
1,418 |
568 |
$10K |
| 83690 |
|
2,124 |
1,685 |
$9K |
| 84443 |
|
917 |
740 |
$9K |
| 71260 |
|
23 |
12 |
$8K |
| 81025 |
|
926 |
776 |
$7K |
| 72125 |
|
98 |
62 |
$7K |
| 85027 |
|
2,547 |
1,802 |
$7K |
| 96374 |
|
3,507 |
2,773 |
$7K |
| 87811 |
|
218 |
182 |
$7K |
| 0003U |
Infec agen detec ampli probe |
58 |
47 |
$6K |
| 87502 |
|
105 |
90 |
$6K |
| 87086 |
|
1,170 |
1,003 |
$6K |
| 71045 |
|
4,654 |
2,595 |
$5K |
| 0202U |
|
110 |
93 |
$5K |
| 86140 |
|
1,430 |
1,137 |
$4K |
| 82962 |
|
2,593 |
1,057 |
$4K |
| 85007 |
|
2,292 |
1,647 |
$4K |
| 87186 |
|
801 |
672 |
$3K |
| 93005 |
|
4,622 |
3,324 |
$3K |
| 0100U |
|
54 |
50 |
$3K |
| 84703 |
|
488 |
406 |
$3K |
| 80051 |
|
488 |
449 |
$3K |
| 85610 |
|
1,383 |
960 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
63 |
55 |
$3K |
| 82565 |
|
835 |
723 |
$3K |
| 85378 |
|
516 |
412 |
$2K |
| 83735 |
|
768 |
503 |
$2K |
| 94760 |
|
5,184 |
4,203 |
$2K |
| 71275 |
|
22 |
13 |
$2K |
| 87880 |
|
106 |
95 |
$2K |
| 83880 |
|
193 |
164 |
$2K |
| 99203 |
|
44 |
32 |
$2K |
| 99201 |
|
13 |
13 |
$2K |
| 84520 |
|
542 |
495 |
$1K |
| 87081 |
|
96 |
89 |
$1K |
| 84460 |
|
372 |
333 |
$1K |
| 97162 |
|
52 |
38 |
$1K |
| 84450 |
|
327 |
301 |
$1K |
| 73610 |
|
61 |
39 |
$962.13 |
| 96375 |
|
3,178 |
2,329 |
$958.38 |
| 90792 |
|
42 |
13 |
$864.84 |
| 36415 |
|
6,369 |
4,191 |
$800.90 |
| 80143 |
|
67 |
52 |
$687.05 |
| 80179 |
|
66 |
52 |
$649.18 |
| 99204 |
|
18 |
13 |
$601.24 |
| 82247 |
|
161 |
115 |
$470.13 |
| 86618 |
|
38 |
33 |
$416.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,611 |
2,570 |
$406.12 |
| 87641 |
|
91 |
66 |
$309.56 |
| 51702 |
|
15 |
12 |
$303.24 |
| 97530 |
|
178 |
74 |
$265.15 |
| 73030 |
|
28 |
13 |
$234.82 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
4,632 |
2,601 |
$192.21 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,399 |
1,667 |
$184.29 |
| 88305 |
|
108 |
104 |
$182.50 |
| 87205 |
|
60 |
53 |
$182.14 |
| J3490 |
Unclassified drugs |
6,511 |
2,666 |
$179.90 |
| 87070 |
|
28 |
26 |
$176.09 |
| 80061 |
|
12 |
12 |
$124.56 |
| 96376 |
|
621 |
396 |
$103.91 |
| 90471 |
|
58 |
49 |
$95.89 |
| 84075 |
|
28 |
28 |
$93.32 |
| 87077 |
|
24 |
14 |
$83.50 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,969 |
1,625 |
$79.05 |
| 82947 |
|
41 |
37 |
$75.66 |
| J2704 |
Injection, propofol, 10 mg |
1,098 |
888 |
$72.63 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,001 |
2,255 |
$59.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
925 |
713 |
$49.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,666 |
1,294 |
$45.38 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
418 |
263 |
$44.27 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,198 |
1,021 |
$39.24 |
| 99219 |
|
55 |
52 |
$25.52 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,926 |
1,058 |
$17.28 |
| J2060 |
Injection, lorazepam, 2 mg |
34 |
25 |
$1.83 |
| 99156 |
|
25 |
24 |
$0.55 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
75 |
55 |
$0.36 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
47 |
36 |
$0.09 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
28 |
26 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
82 |
51 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
242 |
201 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
148 |
117 |
$0.00 |
| A9270 |
Non-covered item or service |
1,123 |
193 |
$0.00 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
237 |
197 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
73 |
53 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
21 |
13 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
13 |
12 |
$0.00 |
| 99217 |
|
26 |
24 |
$0.00 |
| 94761 |
|
20 |
12 |
$0.00 |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
18 |
16 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
70 |
48 |
$0.00 |
| 73630 |
|
16 |
12 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
12 |
12 |
$0.00 |